Putting adoptive T cell therapy on the path to regulatory approval

Share :
Published: 10 Mar 2015
Views: 4349
Rating:
Save
Prof Antoni Ribas – UCLA Jonsson Comprehensive Cancer Center, Los Angeles, USA

Prof Ribas talks to ecancertv at TAT 2015 about adoptive T-cell therapy approaches and their current stage of clinical development. He also discusses the challenges of moving this personalised approach to cancer therapy into the clinic.